Convatec Group Plc has disclosed that non-executive director Jens Viebke bought 24,400 ordinary shares on the London Stock Exchange on 13 October 2026. Based on the reported figures, the purchase was worth about £56,000.

What was announced

In a notification published on 14 October 2026, Convatec Group Plc (LSE:CTEC) reported a share purchase by Jens Viebke, one of its non-executive directors. The notification is marked as an initial notification, rather than an amendment to an earlier filing.

The transaction was a purchase of ordinary shares of 10p each. It was carried out on the London Stock Exchange (XLON) on 13 October 2026, the day before the announcement.

This was a purchase made by the director on the market. The notification does not describe it as an award, a grant or the vesting of a share plan.

The numbers

Mr Viebke bought 24,400 shares at £2.298 per share. The notification does not state a total. Based on the reported figures, 24,400 shares multiplied by £2.298 comes to £56,071.20, or about £56,000.

The notification does not state Mr Viebke's total shareholding after the purchase. It is therefore not possible to tell from this announcement whether this was his first holding in the company or an addition to an existing stake.

Background

Convatec is a FTSE-listed medical products and technologies company. Its products serve areas including advanced wound care, ostomy care, continence care and infusion care. Non-executive directors are not part of the executive management team. Their role is to oversee the board's decisions and to hold executives to account.

Under the UK Market Abuse Regulation (UK MAR), directors and other persons discharging managerial responsibilities must notify the company and the Financial Conduct Authority of their dealings in the company's shares within three business days. The company then publishes the details. Directors may only deal outside closed periods, such as the period before results, and usually need clearance under the company's dealing code.

Market participants often watch purchases by directors with their own money, as they can show a director's willingness to increase their exposure to the company. Directors buy shares for many reasons, however, and a single purchase is not a reliable guide to how a company will perform. The notification does not state Mr Viebke's reasons for buying.

What to watch next

Investors may watch for any further dealing notifications from Convatec (LSE:CTEC) directors and for a disclosure of Mr Viebke's total holding, for example in the company's next annual report. Convatec's scheduled trading updates will remain the main guide to the group's operating performance.